Edgewise Therapeutics EWTX
NASDAQ EWTX
$40.01 +0.36 (+0.91%)
At close: Oct 22, 2026 · 4:00 PM EDT

Edgewise Therapeutics (EWTX) Price to Sales (2024 - 2026)

Updated

Analysis

Edgewise Therapeutics (EWTX) Price to Sales (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Edgewise Therapeutics 4.31 Bn 2.73 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 195.45
Mar 31, 2026 147.52
Sep 30, 2025 72.30
Jun 30, 2025 57.94
Mar 31, 2025 87.45
Dec 31, 2024 101.21
API Access

Edgewise Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=EWTX&period=max&api_key=YOUR_API_KEY